Nuomao

Nuomao (formerly Nuomao Medical) is an innovative medical company under the Denovo Medical Group, dedicated to the research and development, manufacturing, sales, and technical support of interventional medical devices for atrial fibrillation electrophysiology and stroke prevention. Its main products include electrophysiological devices for atrial fibrillation treatment and left atrial appendage occluders for stroke prevention.The company has a professional R&D team. Its core product, CardioPulse, an atrial fibrillation pulsed field ablation device, has completed design and development. SeaLA, the left atrial appendage occluder, has been approved to enter the special review process for innovative medical devices by the NMPA's Center for Medical Device Evaluation, and has successfully completed patient enrollment for NMPA registration clinical trials.